Didier Raoult and the IHU will contest the refusal of the National Medicines Safety Agency to authorize the use of hydroxychloroquine against Covid-19.

video

Source: France Soir

Professor Raoult mandates lawyer Fabrice Di Vizio to lodge an appeal with the Council of State and a criminal complaint after the refusal of the Medicines Agency to authorize more broadly hydroxychloroquine.

Didier Raoult and the IHU will contest the refusal of the National Medicines Safety Agency (ANSM) to authorize the use of hydroxychloroquine against Covid-19. Mandated by the IHU, lawyer Di Vizio sent a request for annulment on Thursday to the Council of State in accordance with the possibility given by such a decision. In addition, a complaint against the agency and its director Dominique Martin for endangering the life of others will be filed on Friday.
Me di Vizio explains to us.






Related: Professor Raoult Sues the French Health Authorities: Could Hydroxychloroquine be Rehabilitated in Court?

HCQ is effective for COVID-19 when used early: analysis of 132 studies

Hydroxychloroquine Not Linked to Longer Heart Rhythm Intervals in Rheumatoid Arthritis or Lupus Patients

Dr. Vladimir Zelenko leads a White House petition asking Dr. Fauci and 3 others be charged and brought to justice for “Crimes Against Humanity / Mass Murder”

Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »